Social isolation induces succinate dehydrogenase dysfunction in anxious mice

Neurochem Int. 2022 Dec:161:105434. doi: 10.1016/j.neuint.2022.105434. Epub 2022 Oct 14.

Abstract

We have previously reported social isolation induces anxiety-like behavior, cognitive decline, and reduction in brain ATP levels in mice. These changes were ameliorated by treatment with dihydromyricetin (DHM), a compound that positively modulates γ-aminobutyric A (GABAA) receptor. To gain further insight into the subcellular mechanisms underlying these changes, we utilized a social isolation-induced anxiety mouse model and investigated changes in mitochondrial oxidative capacity via the electron transport chain. We found that 4 weeks of social isolation decreased ATP levels by 43% and succinate dehydrogenase capacity by 52% of the control, while daily DHM (2 mg/kg oral) administration restored succinate dehydrogenase capacity. These results suggest that social isolation decreased mitochondrial capacity to generate ATP. DHM can be developed to be a therapeutic against anxiety and mitochondrial stress.

Keywords: Anxiety; Complex II; Dihydromyricetin; Social isolation; Stress; Succinate dehydrogenase.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate
  • Animals
  • Anxiety / drug therapy
  • Cognitive Dysfunction* / drug therapy
  • Mice
  • Social Isolation
  • Succinate Dehydrogenase* / therapeutic use

Substances

  • Succinate Dehydrogenase
  • Adenosine Triphosphate